Mobile health in adults with congenital heart disease: current use and future needs

M J Schuuring1,2, A P Backx3, R Zwart3

  • 1Department of Cardiology, Academic Medical Center, Amsterdam, The Netherlands. m.j.schuuring@amc.uva.nl.

Insights

Adults with congenital heart disease (CHD) rarely use mobile health (mHealth) but are eager to adopt it for better symptom monitoring. Future mHealth initiatives are needed to improve outcomes for this lifelong condition.

Area of Science:

  • Cardiology
  • Digital Health
  • Patient Monitoring

Background:

  • Adults with congenital heart disease (CHD) face lifelong cardiac events, including arrhythmias and heart failure.
  • Current care models have a high cardiac event rate despite ongoing management.
  • Mobile health (mHealth) offers potential for enhanced daily monitoring and timely intervention.

Purpose of the Study:

  • To investigate current mHealth adoption rates among adults with CHD.
  • To determine the future mHealth needs and preferences of this population.

Main Methods:

  • A questionnaire-based study was conducted with adult CHD patients at an outpatient clinic.
  • Patients with mental impairment or inability to read/write Dutch were excluded.
  • 118 consecutive patients participated in the study.

Main Results:

  • 92% of participants owned a smartphone, but only 14% currently used mHealth.
  • A significant majority (75%) expressed willingness to start using mHealth.
  • Patients desired mHealth for information on physical health and symptom progression.
  • Older age correlated with lower current smartphone usage, but not with mHealth interest.

Conclusions:

  • The adult CHD population underutilizes mHealth despite high smartphone ownership.
  • There is substantial motivation within this group to adopt mHealth solutions.
  • Development of new mHealth initiatives is crucial for lifelong surveillance, potentially reducing morbidity and mortality and improving quality of life.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
611
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
574
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
459
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
705
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
451
Pulse rhythm01:30

Pulse rhythm

Pulse rhythm refers to the pattern of pulsations within specific intervals, offering valuable insights into the regularity or irregularity of the heart's beats as observed through the pattern of pulsation within specific intervals. A regular pulse exhibits a consistent heart rate with uniform waveforms and pulsation force, variations of which can be classified as normal, weak, or bounding.
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...
1.6K